A phase II trial of doxorubicin (DXR) and gemcitabine (GMZ) administered in patients with metastatic breast cancer (MBC)
Year: 2005
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: A. Bensalem, K. Bouzid
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W976288342
